We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+31.61%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$561M
AUM Growth
+$315M
Cap. Flow
+$248M
Cap. Flow %
44.2%
Top 10 Hldgs %
35.2%
Holding
112
New
30
Increased
42
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$16.6M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$12.9M
3
MDCO
Medicines Co
MDCO
+$12.8M
4
AMGN icon
Amgen
AMGN
+$12.7M
5
BIIB icon
Biogen
BIIB
+$12.6M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.11M
2
HCA icon
HCA Healthcare
HCA
+$3.85M
3
ILMN icon
Illumina
ILMN
+$3.51M
4
ELV icon
Elevance Health
ELV
+$2.58M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 73.05%
2 Energy 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
1
Ultragenyx Pharmaceutical
RARE
$2.46B
$28.4M 5.06%
400,000
+260,000
+186% +$16.6M
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
$23.4M 4.18%
650,000
+560,000
+622% +$12M
ZBH icon
3
Zimmer Biomet
ZBH
$18.5B
$22.1M 3.94%
175,100
+72,100
+70% +$8.91M
BIIB icon
4
Biogen
BIIB
$29.8B
$20.3M 3.63%
65,000
+42,500
+189% +$12.6M
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$18.4M 3.28%
150,000
+100,000
+200% +$12.9M
AMGN icon
6
Amgen
AMGN
$210B
$18.4M 3.27%
110,000
+75,000
+214% +$12.7M
GWPH
7
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$17.3M 3.08%
+130,000
New +$12.4M
PFE icon
8
Pfizer
PFE
$145B
$16.9M 3.02%
527,000
+316,200
+150% +$10.6M
OMED
9
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$16.6M 2.95%
1,450,000
+817,800
+129% +$9.52M
CELG
10
DELISTED
Celgene Corp
CELG
$15.7M 2.8%
150,000
+25,000
+20% +$2.71M
CELG
11
CALL
DELISTED
Celgene Corp
CELG
$15.7M 2.8%
+150,000
New +$16.2M
MDCO
12
DELISTED
Medicines Co
MDCO
$15.1M 2.69%
400,000
+340,000
+567% +$12.8M
GBT
13
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15M 2.67%
650,000
+350,000
+117% +$6.67M
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
$13.3M 2.38%
200,000
+100,000
+100% +$6.37M
SHPG
15
DELISTED
Shire pic
SHPG
$12.6M 2.25%
65,000
+5,000
+8% +$975K
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$12.5M 2.22%
330,000
+180,000
+120% +$3.97M
MZOR
17
DELISTED
Mazor Robotics Ltd.
MZOR
$10.3M 1.84%
400,000
+200,000
+100% +$4.43M
ALNY icon
18
Alnylam Pharmaceuticals
ALNY
$29.5B
$10.2M 1.81%
150,000
+125,000
+500% +$8.82M
DERM
19
DELISTED
Dermira, Inc.
DERM
$10.1M 1.81%
300,000
+150,000
+100% +$4.83M
GILD icon
20
Gilead Sciences
GILD
$163B
$9.49M 1.69%
120,000
-15,000
-11% -$1.22M
MRK icon
21
Merck
MRK
$316B
$9.36M 1.67%
157,200
+26,200
+20% +$1.53M
GKOS icon
22
Glaukos
GKOS
$10.1B
$9.06M 1.61%
240,000
+105,000
+78% +$3.47M
EXEL icon
23
Exelixis
EXEL
$13.8B
$8.95M 1.6%
700,000
+350,000
+100% +$3.78M
TVTY
24
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$8.73M 1.56%
330,000
+105,000
+47% +$2.12M
BIIB icon
25
CALL
Biogen
BIIB
$29.8B
$7.83M 1.4%
+25,000
New +$7.4M
1
2 3 4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2016 Portfolio in Review

As of Q3 2016, Iguana Healthcare Management held 112 positions worth $561M, up 128% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Iguana Healthcare Management deployed $248M of net new capital in Q3 2016, opening 30 new positions and adding to 42 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $7.01M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 78% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Elevance Health, an estimated $2.58M trimmed.

  • Iguana Healthcare Management's largest Q3 2016 buy was Bristol-Myers Squibb: 130,000 shares worth $7.01M.
  • Iguana Healthcare Management added most to Ultragenyx Pharmaceutical in Q3 2016, an estimated $16.6M increase.
  • Iguana Healthcare Management's biggest Q3 2016 reduction was Elevance Health, cutting an estimated $2.58M.
  • Iguana Healthcare Management fully exited Baxter International in Q3 2016, selling an estimated $6.11M.
  • Iguana Healthcare Management's ten largest holdings make up 35% of its $561M portfolio in Q3 2016.
  • Iguana Healthcare Management opened 30 new positions and closed 33 in Q3 2016.
  • Iguana Healthcare Management's portfolio value rose 128% quarter-over-quarter to $561M.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.